Business Wire

COLOPL Group Blockchain Game Company Brilliantcrypto, Confirms Partnership with Coincheck Ahead of IEO

20.7.2023 09:00:00 EEST | Business Wire | Press release

Share

Brilliantcrypto, Inc. (HQ: Minato City Tokyo, CEO: Naruatsu Baba, henceforth “Brilliantcrypto”) has partnered with the crypto asset trading service provider Coincheck, Inc. (HQ: Shibuya City Tokyo, CEO: Satoshi Hasuo, henceforth “Coincheck”) ahead of an IEO※1 (Initial Exchange Offering, henceforth “IEO”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230719966068/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Brilliantcrypto

Brilliantcrypto was established in November 2022 as a wholly owned subsidiary of COLOPL, Inc. (CEO: Takashi Miyamoto, HQ: Minato City Tokyo), to carry out GameFi※2 projects using blockchain technology.

With this partnership, and through the interconnected business of Brilliantcrypto’s currently in-development blockchain game and Coincheck’s crypto asset trading service, the two companies will work together in creating a new game experience and GameFi market on the global stage.

The large-scale Japanese blockchain game project currently in development shall introduce “Proof of Gaming,” a new concept that works for the benefit of others (through guaranteeing value), inspired by the “Proof of Work”※3 mechanism of Bitcoin. Through doing this, it aims to make sustainable play-to-earn※4 a reality.

By utilizing the crypto asset exchange user base and sales network of Coincheck, which is the largest scale exchange and has the best track record with IEOs among domestic crypto exchanges, Brilliantcrypto plans to acquire trust, and aims to achieve a highly enthusiastic user base from the launch period of the game.

Brilliantcrypto will be holding a presentation on July 25th 14:00 JST at the “WebX 2023” event, which will be held at the Tokyo International Forum on July 25th and July 26th. WebX 2023 is a large-scale global conference where the main players in Web3 from countries around the world will gather. On the day, the founder and current chairman of COLOPL, Inc., Mr. Naruatsu Baba will be presenting.

You can view the online livestream by following the link below.
https://www.youtube.com/watch?v=0iEFIMpkf9Q

Comment from Isaka Tomoyuki (Coincheck, Vice-President, Executive Committee Member & Crypto Asset Operations Department Manager)

The GameFi market is still developing, and there is a demand for this new type of game experience that combines finance and entertainment using blockchain technology. Currently, there are many debates taking place about GameFi around the world. But I believe that between theorizing about it, and actually shaping it into something that you can implement into the design of a game that is actually playable, there exists an extraordinarily large gap.

The COLOPL group and its Chief Creator Naruatsu Baba are a rare force in the industry that bridges that gap by delivering original game design aligned with new eras in the gaming industry to their users. I am therefore very pleased to be working on an IEO with the creative team from Brilliantcrypto which is spearheaded by Mr. Baba.

As a leading company for IEOs and crypto asset exchange in Japan, we want to put our full support behind companies that aim to develop the Web3/Crypto industry, or creators that are giving this new type of game design a challenge.

Comment from Naruatsu Baba (CEO of Brilliantcrypto)

Brilliantcrypto was established to take on the challenges of blockchain gaming, and create games that truly shine and stand out. We feel empowered and elated that Coincheck felt a deep connection with our vision “to harness the power of games and blockchain technology to create new value,” and thus decided to become our IEO partner.

Through the partnership of our company, which has spent many years using technology and individualistic ideas to carry out business in the mobile gaming industry, with Coincheck, the largest cryptocurrency exchange in the domestic market, we aim to make a huge impact in not only the Japanese Web3 industry, or even just in the gaming industry, but in all areas of the world.

On July 25th at the WebX 2023 event, which is to be held at the Tokyo International Forum, I plan to deliver a presentation personally and reveal the project to the world. Please look forward to our project, which will bring a never-seen-before, new type of value out into the world.

※1: IEO describes the public offering, sale, and distribution of crypto assets (tokens) that takes place after a project audit/inspection with crypto assets exchange as the medium, following the rules of the Japanese domestic regulation. Until now there have been 4 examples of IEOs performed domestically. Coincheck has carried out two of these including the very first domestic IEO, through the Coincheck IEO platform.

※2: GameFi is a word that combines Game and Finance to describe games that include mechanisms through which one can earn through gameplay, which is made possible by integrating blockchain technology with crypto assets.

※3: Proof of Work (PoW) is one of the consensus algorithms that allows crypto assets to be mined. It allows the transaction and sending of crypto assets, starting with Bitcoin, to be correctly recorded on the blockchain through calculations and verification work. This calculation and verification work is called “mining,” and those who carry it out are called “miners.” PoW is the process in which agreement is reached that the data is correct between the miners through mining.

※4: Play-to-earn is a concept which describes games which make it possible to earn through gameplay, made possible by integrating blockchain technology with crypto assets.

■About Coincheck

Coincheck, Inc. operates a crypto assets exchange platform which for 4 years in a row, has been No.1 in application downloads in that category*. Coincheck’s mission is “Making Exchange of New Values Easier.” Using a foundation of the latest technology and the highest level of security, it aims to create the best service whereby users can feel closer to the “exchange of new values,” which is brought about through crypto assets and blockchain technology.

*Scope: Domestic Crypto Assets Exchange Platforms. Period: 2019/01〜2022/12 Data from App Tweak

Company Name: Coincheck, Inc.
Headquarters: Tokyo, Shibuya City, Maruyamacho, 3-6, 12F E. Space Tower
Founded: 2012/08/28
Executive Director: Satoshi Hasuo
Crypto Asset Exchange Business Registration: Kanto Local Finance Bureau No. 00014
Coincheck, Inc. Corporate Site: https://corporate.coincheck.com/

■About Brilliantcrypto, Inc.

Brilliantcrypto was established in November 2022 as a wholly owned subsidiary by COLOPL, Inc., to carry out GameFi projects using blockchain technology. It was established to take on the challenges of blockchain gaming, and create games that truly shine and stand out. Using both blockchain technology, and the bountiful knowledge gained through the COLOPL group’s many years creating video games, we will create new value on a global scale.

Company Name: Brilliantcrypto, Inc.
Headquarters: Tokyo, Minato City, Akasaka 9-7-2, 5F & 6F Midtown East
Founded: 2022/11/09
Executive Director: Naruatsu Baba
Brilliantcrypto, Inc. Corporate Site: https://brypto.net

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

<Point of Contact regardings inquiries from the media on this release>
Brilliantcrypto PR Representative: Hugo Church, Naoki Nose, Yasuhiro Noguchi
Mail: press.contact@brilliantcrypto.net

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye